William Mack & Associates
LH icon

William Mack & Associates’s Labcorp LH Stock Holding History

William Mack & Associates’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.9K Buy
+136
New +$42.2K 0.01% 264

Other funds holding LH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

William Mack & Associates's LH Position: Q3 2026 in Review

William Mack & Associates opened a new position in Labcorp (LH) in Q3 2026: 136 shares worth $41.9K. The stake represents 0.01% of the portfolio and ranks #264 among its holdings.

925 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • William Mack & Associates held 136 shares of Labcorp worth $41.9K as of Q3 2026.
  • Labcorp was a new William Mack & Associates position in Q3 2026.
  • Labcorp made up 0.01% of William Mack & Associates's portfolio in Q3 2026, its #264 holding.
  • 925 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.